{
}
Alembic Pharmaceuticals reported a 12.3% profit increase to Rs 153.41 crore for Q2 FY25, with revenue rising 3.3% to Rs 1,647.98 crore. Emcure Pharmaceuticals saw a 38.2% profit surge to Rs 201.55 crore, while Indian Hotels Co Ltd's profit skyrocketed 232.2% to Rs 554.58 crore, driven by strong demand and operational growth.
Abbott India Limited
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
page industries and emami declare interim dividends amid strong quarterly results
Abbott India Limited
Emcure Pharmaceuticals Ltd.
Alembic Pharmaceuticals Limited
Trent Limited
Bajaj Electricals Limited
IND
Harsha V Agarwal
Satish Mehta
Mohan Goenka
Anuj Jain
Elara Securities
Show more
13:33 07.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Finance Mergers & Acquisitions
Retail and Consumer Goods
Global Financial Events
Market Analysis and Predictions
Banking Regulations
Industry Mergers & Acquisitions
CEO Changes
Global Trade Developments
Supply Chain Management
Workplace Trends
Startups & Entrepreneurship
Hedge Funds & Private Equity
Government Economic Policies
Central Bank Actions
Financial Scams and Security
Government Policies
Banking & Investment Regulations
Countries:
Companies:
Barclays PLC
BNP Paribas SA
Tesla, Inc.
Deutsche Bank RV Global PP
Raiffeisen Bank International AG
JPMorgan Chase & Co.
UniCredit S.p.A.
Apple Inc.
Strabag SE
Citigroup Inc.
Kering S.A. (ADRs)
The Goldman Sachs Group, Inc.
Morgan Stanley
Banco BPM S.p.A.
UBS Group AG
Bank of America Corporation
Berner Kantonalbank AG
Google Inc.
Berkshire Hathaway Inc.
Microsoft Corporation
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Japanese Yen
Indian Rupee
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
Russian Ruble
Brazilian Real
Filipino Peso
Malaysian Ringgit
United Arab Emirates Dirham
South African Rand
Indonesian Rupiah
South Korean Won
People: